In reaction to high levels of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and hyperphosphatemia, osteoblasts and osteocytes generate and release FGF23 [1-5]. This evidence concerns the gene FGF23 and hyperphosphatemia.